Ingrid van Beek
- Epidemiology top 1%
- Hepatology top 0.5%
- Public Health, Environmental and Occupational Health top 2%
- Infectious Diseases top 2%
- General Health Professions top 5%
- Co-authors
- John KaldorAlex WodakGregory J. DoreRobyn DwyerRichard P. MattickJames ShearerStuart GilmourJo Kimber
- Topics
- HIV, Drug Use, Sexual Risk (30 papers)Hepatitis C virus research (24 papers)Hepatitis B Virus Studies (19 papers)
- Cited by
- HepatologyEpidemiologyToxicology
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Ingrid van Beek
66 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 130
- Epidemiology 2.0k
- Hepatology 1.1k
- Public Health, Environmental and Occupational Health 743
- Infectious Diseases 592
- General Health Professions 344
Countries citing papers authored by Ingrid van Beek
This map shows the geographic impact of Ingrid van Beek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid van Beek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid van Beek more than expected).
Fields of papers citing papers by Ingrid van Beek
This network shows the impact of papers produced by Ingrid van Beek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid van Beek. The network helps show where Ingrid van Beek may publish in the future.
Co-authorship network of co-authors of Ingrid van Beek
This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid van Beek. A scholar is included among the top collaborators of Ingrid van Beek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid van Beek. Ingrid van Beek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 32 | |
| 3 | 50 | |
| 4 | SYDNEY NALOXONE DISTRIBUTION PROGRAM - WHAT CLINICIANS AND CLIENTS THINK | 4 |
| 5 | Effect of pegylated interferon-alpha-2a treatment on mental health during recent hepatitis C virus infection | 5 |
| 6 | 68 | |
| 7 | 17 | |
| 8 | 46 | |
| 9 | 12 | |
| 10 | 115 | |
| 11 | 53 | |
| 12 | 1 | |
| 13 | 19 | |
| 14 | 15 | |
| 15 | 36 | |
| 16 | 23 | |
| 17 | 2 | |
| 18 | 88 | |
| 19 | 61 | |
| 20 | 55 |
About Ingrid van Beek
Ingrid van Beek is a scholar working on Hepatology, Toxicology and Epidemiology, having authored 68 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (30 papers), Hepatitis C virus research (24 papers) and Hepatitis B Virus Studies (19 papers). The work is most often cited by research in Hepatology (1.1k citations), Epidemiology (2.0k citations) and Toxicology (181 citations). Ingrid van Beek has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include John Kaldor, Alex Wodak, Gregory J. Dore, Robyn Dwyer, Richard P. Mattick, James Shearer, Stuart Gilmour, Jo Kimber, Lisa Maher and Janaki Amin. Their work appears in journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.